About ARIDIS PHARMACEUTICALS, INC.
Aridis Pharmaceuticals is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases, particularly targeting antibiotic-resistant bacteria and viral infections. The company utilizes proprietary technology platforms to discover rare, potent human monoclonal antibodies from patients.
Development of novel, differentiated therapies for infectious diseasesDiscovery of rare, potent human monoclonal antibodies from convalescent infected patientsCreation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infectionsInhalable anti-infective therapies effective against antibiotic-resistant bacteriaPreclinical and clinical development of monoclonal antibodies and small molecule anti-infectives
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ARIDIS PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.